Secondly, we have only done scrna-seq and bulk RNA-seq analyses and in vitro experiments, and we need large sample and multi-center research to further explore the relationship between IGFBP7, FOSL2, the IGFBP7 Risk Score (IGRS), and glioma. This evidence concerns the gene FOSL2 and central nervous system cancer.